Development of Frailty Prevention Clinic in Geriatric Comprehensive Clinic RSCM:
1 other identifier
interventional
220
1 country
1
Brief Summary
There is an increasing number of elderly population, not only in Indonesia, but also in the world. With increasing of age, there is also an increasing number of elderly with sarcopenia and frailty. Both of the diseases can lead to dependency, decrease quality of life, and morbidity. Besides nutrition, physical activity, especially resistance training is proven to be beneficial in improving sarcopenia and frailty condition. Currently in Cipto Mangunkusumo National Hospital (RSCM), there is no comprehensive frailty prevention clinic in the geriatric inpatient clinics. This research can be the base of frailty and sarcopenia treatment in RSCM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 17, 2022
CompletedFirst Posted
Study publicly available on registry
August 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2022
CompletedAugust 22, 2022
August 1, 2022
10 months
August 17, 2022
August 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Frailty Status
The FRAIL scale includes 5 components: Fatigue, Resistance, Ambulation, Illness, and Loss of weight (10). Frail scale scores range from 0-5 (i.e., 1 point for each component; 0=best to 5=worst) and represent frail (3-5), pre-frail (1-2), and robust (0) health status
12 weeks
Sarcopenia Status
Measured using: * BIA: \<7.0 kg/m2 in men and \<5.7 kg/m2 in women * Five times sit to stand: ≥12 seconds * Hand-grip strength: \<28 kg for men and \<18 kg for women
12 weeks
Walking Speed
\<1.0 m/s
12 weeks
Patient's Quality of Life
Measured by EQ-5D: ranging from 0 ('worst imaginable health') to 100 ('best imaginable health')
12 weeks
Secondary Outcomes (2)
Prevalence of Frailty
12 weeks
Prevalence of Sarcopenia
12 weeks
Study Arms (2)
Control
ACTIVE COMPARATOR12-week of Standard Therapy using elastic-band
Intervention
EXPERIMENTAL12-week of Resistance Training developed by RSCM using sand-bag
Interventions
Resistance training developed by the researcher (SCR-RSCM) for 12 weeks
Eligibility Criteria
You may qualify if:
- Patients 60 years old or orlder
- Categorized as Pre-frail or Frail based on FRAIL criteria
- Is not in routine physical activity in the past 3 months
- Succeeded Mini Physical Performance Test with score 11 or more
You may not qualify if:
- Cognitive Disturbance (Abbreviated Mental Test \< 8)
- Not consenting to join the trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cipto Mangunkusumo National Hospital
Jakarta, Jakarta Pusat, 10310, Indonesia
Related Publications (3)
Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, Kojima T, Kuzuya M, Lee JSW, Lee SY, Lee WJ, Lee Y, Liang CK, Lim JY, Lim WS, Peng LN, Sugimoto K, Tanaka T, Won CW, Yamada M, Zhang T, Akishita M, Arai H. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2. doi: 10.1016/j.jamda.2019.12.012. Epub 2020 Feb 4.
PMID: 32033882RESULTMienche M, Setiati S, Setyohadi B, Kurniawan J, Laksmi PW, Ariane A, Tirtarahardja G. Diagnostic Performance of Calf Circumference, Thigh Circumference, and SARC-F Questionnaire to Identify Sarcopenia in Elderly Compared to Asian Working Group for Sarcopenia's Diagnostic Standard. Acta Med Indones. 2019 Apr;51(2):117-127.
PMID: 31383826RESULTCruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169.
PMID: 30312372RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof
Study Record Dates
First Submitted
August 17, 2022
First Posted
August 22, 2022
Study Start
January 1, 2022
Primary Completion
October 31, 2022
Study Completion
November 30, 2022
Last Updated
August 22, 2022
Record last verified: 2022-08